AstraZeneca was hit with a patent infringement lawsuit Tuesday in Delaware District Court. The suit was brought by Farnan LLP on behalf of Bristol-Myers Squibb and inventors and other licensees of an antibody called nivolumab that prevents certain proteins from inhibiting the body’s anti-cancer response. The court case pursues claims that a cancer therapy sold by the defendant infringes on the plaintiffs’ patents for nivolumab. Counsel have not yet appeared for the defendants. The case is 1:23-cv-00459, Bristol-Myers Squibb Co. et al v. AstraZeneca Pharmaceuticals LP et al.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector. Read the complaint here: